Mesenchymal stem cells in combination with low-dose rapamycin significantly prolong islet allograft survival through induction of regulatory T cells. [electronic resource]
Producer: 20190517Description: 619-625 p. digitalISSN:- 1090-2104
- Allografts -- drug effects
- Animals
- Cell Differentiation -- drug effects
- Combined Modality Therapy
- Dose-Response Relationship, Drug
- Graft Survival -- drug effects
- Inflammation -- pathology
- Islets of Langerhans Transplantation
- Kidney -- drug effects
- Lymph Nodes -- drug effects
- Mesenchymal Stem Cell Transplantation
- Mesenchymal Stem Cells -- cytology
- Mesentery -- drug effects
- Mice, Inbred C57BL
- Sirolimus -- pharmacology
- Spleen -- drug effects
- T-Lymphocytes, Regulatory -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.